Skip to content
Screener

Nuvectis Pharma, Inc. NVCT Q2 2026 earnings

Reported August 4, 2026 · Before market open

EPS-$0.30Miss by $0.04
EPS estimate-$0.26

Next report

Nov 3, 2026 (in 2 months)
EPS estimate-$0.22

FAQ

When did Nuvectis Pharma, Inc. report Q2 2026 earnings?
Nuvectis Pharma, Inc. (NVCT) reported Q2 2026 earnings on August 4, 2026 before market open.
What were Nuvectis Pharma, Inc.'s Q2 2026 revenue and EPS?
Nuvectis Pharma, Inc. reported eps of $-0.30 for Q2 2026.
Did Nuvectis Pharma, Inc. beat estimates in Q2 2026?
EPS missed the consensus estimate of $-0.26 by $0.04.
How did Nuvectis Pharma, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 0.0% from $-0.30.
Where can I find Nuvectis Pharma, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001104659-26-090094) and the 10-Q periodic report (0001104659-26-090109) directly on SEC EDGAR. The filing index links above go to sec.gov.